CYBB and glioblastoma: Therefore, the data confirmed the general contribution of CYBB in supporting TMZ resistance irrespective of the original properties of the mesenchymal phenotype in GBM cells, despite the level of impact potentially varying between mesenchymal and non-mesenchymal GBM cells.